ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Saturday, 7 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Merger & Restructuring

Morepen Laboratories Merger & Restructuring Worth ₹20 Cr

Morepen Laboratories has invested Rs. 20 Crore via a rights issue in its wholly-owned subsidiary, Morepen RX Limited, to strengthen its capital base.

Key figures
Value₹20.00 Cr
Source

NSE filing, NSE: MOREPENLAB. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Morepen Laboratories Ltd: key numbers

Share price
₹92.25
Market cap
₹5,055 Cr
Revenue (annual)
₹1,806 Cr
Net profit (annual)
₹94.88 Cr
P/E (TTM)
26.8×Sector 43.0×
Promoter holding
35.65%+0.00% QoQ
FII holding
3.43%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Morepen Laboratories Ltd

All →
13:32 IST NSE
Financial Results

Morepen Laboratories Q2 FY27 Results: Net Profit ₹88.9 Cr, Up 117.4% YoY

Morepen Laboratories Ltd reported revenue from operations of ₹746.5 Cr (+81.4% YoY) and net profit of ₹88.9 Cr (+117.4% YoY) for Q2 FY27.

Key figure
Net profit ₹88.9 Cr · +117.4% YoY

Other merger & restructuring announcements

All →